Microvascular Therapeutics
Biotechnology - , Arizona, United States
Microvascular Therapeutics Employees
Microvascular Therapeutics Details
Microvascular Therapeutics is a clinical stage biotechnology which pioneers in ultrasound contrast agents and theranostics. We are looking for funds in order to further develop our two main products in 4 therapeutic indications including cardiovascular. We have a bridge loan open for up to $5M. We have several follow-on products derived from the platform technology. Microvascular Therapeutics (MVT) is developing a new improved ultrasound contrast agent MVT-100 via the 505(b)(2) pathway. The founders of MVT developed Definity®, the world's #1 selling ultrasound contrast agent. Definity requires refrigerated temperature storage and has side effect of back pain. MVT-100 is a room temperature storage product and designed to eliminate the back pain. MVT has multiple theranostic products in its pipeline with multi-billion dollar market potential, the first one of which is expected to be regulated via the device pathway. MVT has 5 active NIH grants. MVT has an open Bridge Round at very favorable terms.
Microvascular Therapeutics Technologies
Ad Servers
DoubleClick
Email Providers
Outlook
Load Balancers
Varnish
Social Login
Facebook Login (Connect)
Hosting
Google Cloud Hosting
Other
Mobile Friendly